Posaconazol kan øge plasmaniveauerne af HMG- CoA reduktasehæmmere, som metaboliseres af CYP3A4, betydeligt.
Posaconazole may substantially increase plasma levels of HMG-CoA reductase inhibitors that are metabolised by CYP3A4.